Published in Blood Press on January 01, 2009
Management of hypertension and diabetes in obesity: non-pharmacological measures. Int J Hypertens (2011) 0.94
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32
Neuroscience data and tool sharing: a legal and policy framework for neuroinformatics. Neuroinformatics (2003) 1.64
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58
Neuroinformatics: the integration of shared databases and tools towards integrative neuroscience. J Integr Neurosci (2002) 1.58
Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicentre study. Drugs Aging (2011) 1.44
Does mild pulmonary stenosis progress during childhood? A study of its natural course. Clin Cardiol (2004) 1.44
Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment. J Hypertens (2013) 1.39
[Risk assessment for a first stroke in Spanish hypertensive population in primary care. The ERIC-HTA study]. Med Clin (Barc) (2005) 1.39
Hypertension in children and adolescents. J Hypertens (2004) 1.38
The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J Hypertens (2008) 1.18
High blood pressure in children: clinical and health policy implications. J Clin Hypertens (Greenwich) (2010) 1.18
[Cardiovascular risk by Framingham and SCORE in patients 40-65 years old]. Med Clin (Barc) (2006) 1.13
Reversible posterior leukoencephalopathy secondary to indinavir-induced hypertensive crisis: a case report. Am J Hypertens (2002) 1.13
Differential prognostic effect of systolic blood pressure on mortality according to left-ventricular function in patients with acute heart failure. Eur J Heart Fail (2010) 1.12
Factors affecting the glucosinolate content of kale (Brassica oleracea acephala group). J Agric Food Chem (2007) 1.12
Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors. Blood Press (2010) 1.09
Birth weight impacts on wave reflections in children and adolescents. Hypertension (2002) 1.01
Procedure to consistently obtain endothelial and smooth muscle cell cultures from umbilical cord vessels. Transl Res (2007) 1.00
Studying cross-cultural differences in the development of infant temperament: People's Republic of China, the United States of America, and Spain. Child Psychiatry Hum Dev (2006) 0.97
Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG), a reliable oxidative stress marker in hypertension. Free Radic Res (2007) 0.94
[Prevalence of atrial fibrillation in the Spanish population aged 60 years or more. The PREV-ICTUS study]. Rev Esp Cardiol (2007) 0.93
Metabolomic profiling in blood from umbilical cords of low birth weight newborns. J Transl Med (2012) 0.93
First-year blood pressure increase steepest in low birthweight newborns. J Hypertens (2007) 0.91
Optimization of nano-emulsion preparation by low-energy methods in an ionic surfactant system. Langmuir (2006) 0.90
Gas1 is induced during and participates in excitotoxic neuronal death. Mol Cell Neurosci (2002) 0.90
A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension. J Hypertens (2007) 0.88
Eponym : Grisel syndrome. Eur J Pediatr (2011) 0.88
Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme. Vasc Health Risk Manag (2007) 0.87
Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease. Clin Rheumatol (2006) 0.87
[Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study]. Rev Esp Cardiol (2006) 0.87
Thrombocytopenia associated with levodopa treatment. Arch Intern Med (2003) 0.87
Drug utilization and off-label drug use among Spanish emergency room paediatric patients. Eur J Clin Pharmacol (2010) 0.87
[Evaluation and management of hypertension in Spain. A consensus guide]. Med Clin (Barc) (2008) 0.86
Neuregulins and neuronal plasticity: possible relevance in schizophrenia. Novartis Found Symp (2008) 0.86
Prolactin and 16K prolactin stimulate release of vasopressin by a direct effect on hypothalamo-neurohypophyseal system. Endocrine (2003) 0.86
Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study. J Hypertens (2006) 0.85
Exercise intervention in childhood obesity: a randomized controlled trial comparing hospital-versus home-based groups. Acad Pediatr (2012) 0.85
Birth weight and characteristics of endothelial and smooth muscle cell cultures from human umbilical cord vessels. J Transl Med (2009) 0.85
[Agreement between REGICOR and SCORE scales in identifying high cardiovascular risk in the Spanish population]. Rev Esp Cardiol (2007) 0.84
Childhood blood pressure: a window to adult hypertension. J Hypertens (2003) 0.83
Polymorphisms of antioxidant enzymes, blood pressure and risk of hypertension. J Hypertens (2011) 0.83
Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study. Blood Press (2007) 0.83
Nocturnal blood pressure versus nondipping pattern: what do they mean? Hypertension (2007) 0.83
[Renal involvement in the human immunodeficiency virus infection]. Med Clin (Barc) (2004) 0.83
OASIS-HT: design of a pharmacogenomic dose-finding study. Pharmacogenomics (2005) 0.82
[Control of blood pressure in diabetic patients in primary care setting. DIAPA study]. Med Clin (Barc) (2003) 0.82
Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. Am J Hypertens (2004) 0.82
Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study. Curr Med Res Opin (2008) 0.81
Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension (2005) 0.81
Novel fusion protein derived from vasostatin 30 and vasoinhibin II-14.1 potently inhibits coronary endothelial cell proliferation. Mol Biotechnol (2013) 0.81
Porcine brain microvessel endothelial cells show pro-inflammatory response to the size and composition of metallic nanoparticles. Drug Metab Rev (2013) 0.80
Clinical inertia in poorly controlled elderly hypertensive patients: a cross-sectional study in Spanish physicians to ascertain reasons for not intensifying treatment. Am J Cardiovasc Drugs (2013) 0.80
Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial. J Hypertens (2010) 0.80
Prolactin protects against the methamphetamine-induced cerebral vascular toxicity. Curr Neurovasc Res (2013) 0.80
The kidney in obesity. Curr Hypertens Rep (2015) 0.79
[Prevalence and related factors of overweight and obesity in Spanish population aged 60 years-old or older. The PREV-ICTUS study]. Med Clin (Barc) (2008) 0.79
Prevalence of atrial fibrillation and use of antithrombotics in hypertensive patients aged >or=65 years. The FAPRES trial. Rev Esp Cardiol (2010) 0.79
Reference blood pressure values in childhood: an issue to be solved. J Hypertens (2012) 0.79
[Prevalence of low glomerular filtration rate in the elderly population of Spain. The PREV-ICTUS study]. Med Clin (Barc) (2007) 0.78
Transmitter release in the neuromuscular synapse of the protein kinase C theta-deficient adult mouse. J Comp Neurol (2011) 0.78
Hypertension and target organ damage in children and adolescents. J Hypertens (2007) 0.78
[Factors related to the differences in blood pressure values assessed by auscultatory or oscillometric methods]. Med Clin (Barc) (2006) 0.78
Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el paciente hipertenso ≥ 65 años. El registro FAPRES. Rev Esp Cardiol (2010) 0.78
Role of dihydropyridinic calcium channel blockers in the management of hypertension. Expert Rev Cardiovasc Ther (2013) 0.77
Effectiveness of an Interventional Program to Improve Blood Pressure Control in Hypertensive Patients at High Risk for Developing Heart Failure: HEROIC study. J Clin Hypertens (Greenwich) (2010) 0.77
Twenty-four-hour ambulatory heart rate and organ damage in primary hypertension. Blood Press (2010) 0.77
Protective effect of the 1742(C/G) polymorphism of human cardiotrophin-1 against left ventricular hypertrophy in essential hypertension. J Hypertens (2010) 0.77
Nocturnal hypertension: will control of nighttime blood pressure prevent progression of diabetic renal disease? Curr Hypertens Rep (2004) 0.77
[Prevalence of metabolic syndrome in Spanish population aged 60 years-old or more. PREV-ICTUS, a population-based study]. Med Clin (Barc) (2009) 0.77
Effects of nebivolol and atenolol on central aortic pressure in hypertensive patients: a multicenter, randomized, double-blind study. Blood Press (2013) 0.77
Emotional Eating Scale for children and adolescents: psychometric characteristics in a Spanish sample. J Clin Child Adolesc Psychol (2011) 0.77
Should we perform an echocardiogram in hypertensive patients classified as having low and medium risk? Int J Cardiol (2006) 0.76
Childhood blood pressure: trends and future tracks. Hypertension (2013) 0.76
Influence of obesity in central blood pressure. J Hypertens (2015) 0.76
High-density lipoprotein cholesterol and cardiovascular disease in Spanish hypertensive women. The RIMHA study. Rev Esp Cardiol (2009) 0.76
Relationship of central and peripheral blood pressure to left ventricular mass in hypertensive patients. Rev Esp Cardiol (Engl Ed) (2012) 0.76
Impact of cardiovascular risk factors on oxidative stress and DNA damage in a high risk Mediterranean population. Free Radic Res (2009) 0.76
[Guidelines for the diagnosis, evaluation and treatment of hypertension: the point of view of the Spanish Society of Hypertension]. Med Clin (Barc) (2003) 0.76
Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance? Pediatr Nephrol (2007) 0.75
Out-of-office blood pressure measurement in children and adolescents. J Hypertens (2008) 0.75
Prolactin and blood-brain barrier permeability. Curr Neurovasc Res (2013) 0.75
Chronic hepatitis C and autoimmune cholangitis: a case study and literature review. Dig Dis Sci (2002) 0.75
Association between Opioid Receptor mu 1 (OPRM1) Gene Polymorphisms and Tobacco and Alcohol Consumption in a Spanish Population. Bosn J Basic Med Sci (2015) 0.75
Uncertainty in the assessment of trends in childhood blood pressure. J Hypertens (2012) 0.75
Advance in vascular phenotype assessment in children and adolescents. Hypertension (2010) 0.75
Hypertension in children and adolescents. Blood Press (2003) 0.75
Cold medication containing oral phenylephrine as a cause of hypertension in children. Eur J Pediatr (2007) 0.75
From pioneering to implementing automated blood pressure measurement in clinical practice: Thomas Pickering's legacy. Blood Press Monit (2010) 0.75
The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension. J Hypertens (2017) 0.75
[Obesity and hypertension]. Med Clin (Barc) (2007) 0.75
[In the identification of cardiovascular risk with the SCORE model, could we recommend its calculation interchangeably with total cholesterol or atherogenic index? Concordance between total cholesterol and atherogenic index in the SCORE table]. Rev Esp Cardiol (2011) 0.75
[Origins of hypertension: birth weight, a new issue]. Med Clin (Barc) (2002) 0.75
Effectiveness and tolerability of fixed-dose combination enalapril plus nitrendipine in hypertensive patients: results of the 3-month observational, post-marketing, multicentre, prospective CENIT study. Clin Drug Investig (2009) 0.75
Naphazoline intoxication in children. Eur J Pediatr (2006) 0.75